Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384470 · ClinicalTrials.gov registry record
Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 32
- Enrollment target
NCT05384470 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 32 participants.
The verdict
NCT05384470 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This Phase II STTR program consists of two major goals within the overarching goal of developing and validating a proprietary device (BID2) for marijuana and opioid detection in breath samples.
Interventions
- DRUG Marihuana
- DEVICE BID2 Instrument - breathalyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2024-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05384470
The ClinicalTrials.gov registry entry for NCT05384470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Marihuana is the first listed.
NCT05384470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05384470 about?
NCT05384470 is a clinical study titled "Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry". This Phase II STTR program consists of two major goals within the overarching goal of developing and validating a proprietary device (BID2) for marijuana and opioid detection in breath samples.
What is the current status of trial NCT05384470?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2021-08-01. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT05384470?
The interventions under investigation include: Marihuana (DRUG), BID2 Instrument - breathalyzer (DEVICE).
Who is sponsoring clinical trial NCT05384470?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.